Title: Assessment of Serum Vitamin D3 Level in Patients with Type 2 Diabetes Mellitus
Authors: Mazyar Jabbar Ahmed, Yousf Bahaddin Ahmed
DOI: http://dx.doi.org/10.18535/jmscr/v4i8.99
Abstract
Background: The aim of this article is to determine the association between serum vitamin D level and newly diagnosed type 2 diabetes mellitus in Erbil city.
Methods: This is a case-controle study involving 100 subjects which included 2 groups, 50 type 2 diabetic patients diagnosed recently, 50 healthy individuals as control group. The study is conducted from Aprilto December -2015 in Layla Qasim diabetic center. The data collected from all cases including history and examination all recorded on specially designed questionnaire. From all cases blood sample sent for serum vitamin D3 level.
Results: From the total of 100 subjects, the mean age ofcases was48.8 years and of controls 48.1 The male: female ratio was 1:1 in both cases and controls. The mean serum vitamin D3 level of cases was (9.88 ±6.12) ng/ml and it was significantly lower than the control (14.34±6.4)ng/ml, (p-value=0.001) although both groups lied within the deficient range. Within the cases the vitamin D3 were deficient in 47(94%) of cases in compared to 44(88%) of control group , The serum vitamin D3 level was insufficient in 2(4%) cases in comparing to 4(8%) of control and sufficient in 1(2%) case in comparing to 2(4%) of control.
Conclusion: The mean serum level of vitamin D3 in newly diagnosed type 2 diabetic patients was significantly lower than that of control group, vitamin D deficiency could contribute to etiology of type 2 diabetes mellitus.
Keywords: type 2 diabetes mellitus, serum vitamin D3 level.
References
1. Whiting D, Leonor G, Clara W, Jonathan S . Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research Hand Clinical Practice 2011;94(3): 311-321
2. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG,et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N EnglJMed 2001;345:790-97
3. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 2003;26:645-49
4. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J ClinNutr 2006;84:18-28
5. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo ClinProc 2006;81:353-73
6. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends EndocrinolMetab 2005;16:261-66
7. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92(6):2017-29
8. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J ClinNutr 2004;79(5):820-5
9. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J ClinNutr 2004;80(6):1689S-96S
10. Bikle D. Nonclassic actions of vitamin D. J ClinEndocrinolMetab 2009;94(1):26-34
11. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358 (9292):1500-3
12. Ortlepp JR, Metrikat J, Albrecht M, Von Korff A, Hanrath P, Hoffmann R. The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in health young men. Diabet Med 2003;20(5):451-4
13. Binkly N, Krueger D, Cowgill CS, Plum L, Lake E,Hansen KE, et al. Assay variation confounds the diagnosis of hypovitaminosis D:a call for standardi-zation. J Clin Endocrinol Metab 2004;89(7):315-7
14. Zargar AH, Ahmad S, Masoodi SR, Wani AI, Bashir MI, Laway BA, et al. Vitamin D status in apparently healthy adults in Kashmir valley of Indian subcontinent. Postgrad Med J 2007;83(985):713-6
15. Marwaha RK, Tandon N, Reddy DR, Aggarwal R, Singh R, Sawhney RC, et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J ClinNutr 2005;82(2):477-82
16. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J ClinNutr 2004; 79: 362-71
17. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001; 15: 2579-85
18. Zella JB, DeLuca HF. Vitamin D and autoimmune diabetes. J Cell Biochem 2003; 88: 216–22
19. Bener A, Alsaied A, Al-Ali M, Al-Kubaisi A, Basha B, Abraham A, et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. ActaDiabetol 2009;46(3):183-9
20. Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus.JPediatr 2009;154(1):132-4
21. Littorin B, Blom P, Schölin A, Arnqvist HJ, Blohmé G, Bolinder J, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006;49 (12):2847-52
22. Isaia G , Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001;24:1496
23. Targher G , Bertolini L , Padovani R, Zenari L, Scala L, CigoliniM,Arcaro G . Serum 25-hydroxyvitamin D3 concentrat-ions and carotid artery intima-media thickness among type 2 diabetic patients. ClinEndocrinol (Oxf) 2006;65:593-7
24. Deleskog A, Hilding, Brismar K, Hamsten A ,Efendic S , Ostenson CG . Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia 2012;55:1668-78
25. Forouhi NG, Luan J, Cooper A,Boucher BJ, Wareham NJ . Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57:2619-25
26. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 2011;34:1133-8
27. Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, et al. Prospective associations of vitamin D with beta-cell function and glycemia: the PRO spective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 2011;60:2947–53
28. Janner M, Ballinari P, Mullis PE, Flück CE. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly 2010;140:w13091
29. Pozzilli P, Manfrini S, Crinò A, Picardi A, Leomanni C, Cherubini V, et al. IMDIAB group. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diab-etes. Horm Metab Res 2005;37 (11):680-3
30. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414(6865):782-7
31. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27(12):2813-8
32. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunc-tion. Am J ClinNutr 2004;79 (5):820-5
33. Forouhi NG, Luan J, Hennings S, Wareham NJ. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. DiabetMed 2007;24 (2):200-7
34. Pittas AG, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan DM, et al. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 2012;35:565-73
35. Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007;30:2569-70
36. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njolstad I, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromso Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 2010;27:1107-15.